AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 260: R509-R517, 1991;
0363-6119/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szeto, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szeto, H. H.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 3 509-R517, Copyright © 1991 by American Physiological Society


ARTICLES

Morphine-induced activation of fetal EEG is mediated via central muscarinic pathways

H. H. Szeto
Department of Pharmacology, Cornell University Medical College, New York, New York 10021.

The effect of morphine on fetal electroencephalogram (EEG) was investigated using power spectral analysis. Morphine (0.15-5.0 mg/h) administered directly to the fetal lamb altered fetal EEG in three ways. First, morphine altered the relative incidence of the three preponderant EEG states [high-voltage slow activity (HVSA), transitional, and low-voltage fast activity (LVFA)]. Morphine resulted in a dose-dependent reduction in HVSA, with a reciprocal increase in transitional state at the lower doses and an increase in LVFA at higher doses. Second, morphine resulted in a more fragmented and unstable EEG pattern, with a significant increase in the number of state-to-state transitions. Third, there was a significant increase in the 90% spectral edge frequency as well as relative power distribution in the theta band. Taken together, these data suggest that morphine results in activation of the fetal EEG. This effect was completely abolished by concurrent intracerebroventricular administration of either methyl naloxone or methyl atropine, indicating that it is mediated by specific opioid receptors in the central nervous system and involves activation of central muscarinic pathways.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. C. Taylor, D. Wu, Y. Soong, J. S. Yee, and H. H. Szeto
Opioid Modulation of the Fetal Hypothalamic-Pituitary-Adrenal Axis: The Role of Receptor Subtypes and Route of Administration
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 129 - 135.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online